Time-series RNA-seq reads of SK-MEL-28 cells treated with two concentrations of vemurafenib
Ontology highlight
ABSTRACT: SK-MEL-28 BRAF-mutant melanoma cells were treated with 10µM and 50µM vemurafenib and observed over time in order to elucidate the biological processes of phenotypical adaptation involved in treatment resistance development and identify potential novel targets for future combination therapies.
INSTRUMENT(S): DNBSEQ-G400
ORGANISM(S): Homo sapiens
SUBMITTER: Ninela Miriama Vainselbauma
PROVIDER: E-MTAB-15508 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA